vTv Therapeutics Inc. (VTVT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About vTv Therapeutics Inc.
vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and…
Source: Yahoo Finance
Sector & Industry
vTv Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
vTv Therapeutics Inc. at a Glance
| Company | vTv Therapeutics Inc. |
| Ticker | VTVT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $33.35 |
| Market cap | $131.86M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.75 |
| 52-week high | $44.00 |
| 52-week low | $18.76 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.28 |
| Return on equity (ROE) | -15.80% |
| Debt-to-equity | — |
| Average volume | 74,611 |
| Shares outstanding | 3.95M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 26 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is vTv Therapeutics Inc.'s current P/E ratio?
- vTv Therapeutics Inc. (VTVT) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is vTv Therapeutics Inc.'s market capitalisation?
- vTv Therapeutics Inc.'s market cap is $131.86M based on our latest snapshot. See how it ranks by market cap →
- What is VTVT's 52-week range?
- Over the past 52 weeks, VTVT has traded between $18.76 and $44.00. What does the 52-week range mean? →
- How volatile is vTv Therapeutics Inc. compared to the market?
- vTv Therapeutics Inc. has a beta of 0.28, meaning it has historically moved less than the broader market. What does beta measure? →
- Does vTv Therapeutics Inc. pay a dividend?
- vTv Therapeutics Inc. does not currently pay a dividend according to our latest data.
- What exchange is VTVT listed on?
- VTVT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is vTv Therapeutics Inc. in?
- vTv Therapeutics Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →